654 related articles for article (PubMed ID: 19856544)
1. The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease.
Adler SP; Nigro G
Herpes; 2008 Nov; 15(2):24-7. PubMed ID: 19856544
[TBL] [Abstract][Full Text] [Related]
2. Findings and conclusions from CMV hyperimmune globulin treatment trials.
Adler SP; Nigro G
J Clin Virol; 2009 Dec; 46 Suppl 4():S54-7. PubMed ID: 19781985
[TBL] [Abstract][Full Text] [Related]
3. Hyperimmunoglobulin for prevention of congenital cytomegalovirus disease.
Nigro G; Adler SP
Clin Infect Dis; 2013 Dec; 57 Suppl 4():S193-5. PubMed ID: 24257426
[TBL] [Abstract][Full Text] [Related]
4. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
Buxmann H; Stackelberg OM; Schlößer RL; Enders G; Gonser M; Meyer-Wittkopf M; Hamprecht K; Enders M
J Perinat Med; 2012 Mar; 40(4):439-46. PubMed ID: 22752777
[TBL] [Abstract][Full Text] [Related]
5. [Therapy or prevention of fetal infection by cytomegalovirus with immunoglobulin infusion in pregnant women with primary infection].
Cosmi E; Mazzocco M; La Torre R; Ligi P; Sali E; Nigro G
Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():547-51. PubMed ID: 11424804
[TBL] [Abstract][Full Text] [Related]
6. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
Kagan KO; Enders M; Schampera MS; Baeumel E; Hoopmann M; Geipel A; Berg C; Goelz R; De Catte L; Wallwiener D; Brucker S; Adler SP; Jahn G; Hamprecht K
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):383-389. PubMed ID: 29947159
[TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
Blázquez-Gamero D; Galindo Izquierdo A; Del Rosal T; Baquero-Artigao F; Izquierdo Méndez N; Soriano-Ramos M; Rojo Conejo P; González-Tomé MI; García-Burguillo A; Pérez Pérez N; Sánchez V; Ramos-Amador JT; De la Calle M
J Matern Fetal Neonatal Med; 2019 Feb; 32(4):617-625. PubMed ID: 28978246
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus.
Negishi H; Yamada H; Hirayama E; Okuyama K; Sagawa T; Matsumoto Y; Fujimoto S
J Perinatol; 1998; 18(6 Pt 1):466-9. PubMed ID: 9848763
[TBL] [Abstract][Full Text] [Related]
9. Passive immunization during pregnancy for congenital cytomegalovirus infection.
Nigro G; Adler SP; La Torre R; Best AM;
N Engl J Med; 2005 Sep; 353(13):1350-62. PubMed ID: 16192480
[TBL] [Abstract][Full Text] [Related]
10. [CMV infections].
Pawłowska M; Halota W
Przegl Epidemiol; 2004; 58 Suppl 1():17-21. PubMed ID: 15807153
[TBL] [Abstract][Full Text] [Related]
11. Prevention of maternal-fetal transmission of cytomegalovirus.
Adler SP; Nigro G
Clin Infect Dis; 2013 Dec; 57 Suppl 4():S189-92. PubMed ID: 24257425
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the prevention and treatment of congenital cytomegalovirus infections.
Adler SP; Nigro G; Pereira L
Semin Perinatol; 2007 Feb; 31(1):10-8. PubMed ID: 17317422
[TBL] [Abstract][Full Text] [Related]
13. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
Nigro G
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):977-986. PubMed ID: 29072089
[TBL] [Abstract][Full Text] [Related]
14. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease.
La Torre R; Nigro G; Mazzocco M; Best AM; Adler SP
Clin Infect Dis; 2006 Oct; 43(8):994-1000. PubMed ID: 16983610
[TBL] [Abstract][Full Text] [Related]
15. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight.
Nigro G; Capretti I; Manganello AM; Best AM; Adler SP
J Matern Fetal Neonatal Med; 2015 Jan; 28(2):168-71. PubMed ID: 24660895
[TBL] [Abstract][Full Text] [Related]
16. Maternal-fetal cytomegalovirus infection: from diagnosis to therapy.
Nigro G
J Matern Fetal Neonatal Med; 2009 Feb; 22(2):169-74. PubMed ID: 19253166
[TBL] [Abstract][Full Text] [Related]
17. Congenital cytomegalovirus infection following primary maternal infection in the third trimester.
Gindes L; Teperberg-Oikawa M; Sherman D; Pardo J; Rahav G
BJOG; 2008 Jun; 115(7):830-5. PubMed ID: 18485160
[TBL] [Abstract][Full Text] [Related]
18. Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.
Bravo FJ; Cardin RD; Bernstein DI
J Infect Dis; 2006 Feb; 193(4):591-7. PubMed ID: 16425139
[TBL] [Abstract][Full Text] [Related]
19. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
Seidel V; Hackelöer M; Rancourt RC; Henrich W; Siedentopf JP
Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
[TBL] [Abstract][Full Text] [Related]
20. Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight.
Eskild A; Jenum PA; Bruu AL
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1035-41. PubMed ID: 16232169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
